CN103864958A - Method of preparing high-purity heparin sodium - Google Patents

Method of preparing high-purity heparin sodium Download PDF

Info

Publication number
CN103864958A
CN103864958A CN201310625500.XA CN201310625500A CN103864958A CN 103864958 A CN103864958 A CN 103864958A CN 201310625500 A CN201310625500 A CN 201310625500A CN 103864958 A CN103864958 A CN 103864958A
Authority
CN
China
Prior art keywords
heparin sodium
organic solvent
high purity
preparing high
purity heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310625500.XA
Other languages
Chinese (zh)
Inventor
刘乃山
刘汝荣
迟培升
夏衬来
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd
Original Assignee
QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd filed Critical QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd
Priority to CN201310625500.XA priority Critical patent/CN103864958A/en
Publication of CN103864958A publication Critical patent/CN103864958A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a method of preparing high-purity heparin sodium. The method is characterized in that under a room temperature of 298K, an organic precipitation method is adopted to remove heparin sodium-like impurities dermatan sulfate and chondroitin sulfate in the heparin sodium to prepare high-purity heparin sodium, so that the heparin sodium and similar substances thereof are separated according to solubility difference in different polar solvents. The method is suitable for purifying and separating the sodium-like impurities dermatan sulfate, chondroitin sulfate and the like in the heparin sodium to prepare the high-purity heparin sodium, and has remarkable social and beneficial benefits.

Description

A kind of method of preparing high purity heparin sodium
Technical field
The present invention relates to biological technical field, relate in particular to a kind of method of preparing high purity heparin sodium.
Background technology
Heparin sodium and quasi-heparin substance chondroitin sulfate (CS), dermatan sulfate (DS) all belong to the mixture of mucopolysaccharide family macromolecule, the extraction of polysaccharide separates the technique of great majority employing water extract-alcohol precipitation, alcohol precipitation is different according to the molecular size range of polysaccharide, and carry out separation and purification, so when organic solvent deposit, the product difference that volume fraction difference obtains, according to the molecular weight difference of heparin sodium, CS, DS, precipitate to separate impurity CS, the DS in heparin sodium by distribution with organic solvent.
In existing isolation technique, the ion-exchange-resin process that separated to heparin sodium with similar substance CS, DS, its weak point is: take time and effort, expend reagent, complicated operation, yield are low.
For the deficiency of above-mentioned isolation technique, expend reagent in order to solve existing ion-exchange-resin process, take time and effort, the problems such as complicated operation, the invention provides one can sharp separation heparin sodium and similar substance thereof, prepares the method for high purity heparin sodium, method green non-pollution of the present invention, simple, can effectively separate heparin sodium and similar substance thereof, prepare high purity heparin sodium.
Summary of the invention
The present invention is achieved by the following technical solutions:
Prepare a method for high purity heparin sodium, according to heparin sodium and similar substance thereof, the different solubility in the organic solvent of opposed polarity reaches the separation and purification of heparin sodium and its impurity, thereby prepares highly purified heparin sodium:
Described experimental procedure is as follows:
1, take 5g heparin industry crude product (containing DS, the CS impurity of different amounts),
2, add the salt solution that contains certain percentage ratio to be uniformly dissolved,
3, be V1-V2 (Volume) to adding organic solvent volume multiple in solution,
4, evenly, normal temperature leaves standstill to be preserved for some time in vibration,
5, centrifugal, collecting precipitation, then supernatant liquor is regulated to organic solvent volume multiple is V3-V4, evenly, normal temperature leaves standstill to be preserved in vibration,
6, centrifugal, collecting precipitation, then regulate alcohol volume multiple to be V5-V6 supernatant liquor, centrifugal, collecting precipitation, dries the throw out of every part, weighs.
The concentration of the salt in described step 2 is 2%; Organic solvent in described step 3 is ethanol; Organic solvent volume fraction V1 in described step 3 is that 9.1%, V2 is 28.6%; Time of repose in described step 4 is 2 hours; Organic solvent volume fraction V3 in described step 5 is that 33.3%, V4 is 44.4%; Organic solvent volume fraction V5 in described step 6 is that 47.4%, V6 is 66.7%.
The inventive method is simple, is suitable for heparin sodium and similar substance chondroitin sulfate thereof, dermatan sulfate to carry out the free of contamination separation of quick nondestructive, provides technical support for preparing highly purified heparin sodium.
Brief description of the drawings
Fig. 1 is that percent by volume taking ethanol is as X-coordinate, to precipitate the experimental result picture of quality for the substep ethanol precipitation that ordinate zou was done
Embodiment
Below in conjunction with embodiment, the present invention is further illustrated.
Embodiment 1:
(1) take 5g heparin industry crude product (containing DS, the CS impurity of different amounts);
(2) add and contain 2% salt solution and be uniformly dissolved;
(3) be 9.1%-28.6% (Volume) to adding organic solvent volume multiple in solution;
(4) evenly, normal temperature leaves standstill 2 hours in vibration;
(5) centrifugal, collecting precipitation, then supernatant liquor is regulated to organic solvent volume multiple is 33.3%-44.4%, evenly, normal temperature leaves standstill to be preserved in vibration;
(6) centrifugal, collecting precipitation, then regulate alcohol volume multiple to be 47.4%-66.7% supernatant liquor, centrifugal, collecting precipitation, dries the throw out of every part, weighs.
(7) experimental result of ethanol substep alcohol precipitation is in table 1.
Table 1 ethanol substep alcohol precipitation experimental result
Can find out from Fig. 1 (seeing Figure of description) and associative list 1, the quality product of ethanol fractional precipitation heparin industry crude product gained has three sections: the first section volume fraction of ethanol 10% to 33%, this section precipitation quality maximum, its yield accounts for approximately 62.3% of total mass; The second section volume fraction of ethanol 35% to 47%, the quality of this section precipitation is taken second place, and its yield accounts for 24.2% of total mass; Mass ratio two sections of the 3rd section volume fraction of ethanol from 50% to 62% this section precipitation reduce, and its yield accounts for 12.3%.
From 1the qualitative analysis of H-NMR result is known: HP concentrates on the first section, be that ethanol volume multiple 0.1V-0.4V (9.1%-28.6%) is settled out HP, DS concentrates on the second section, be that ethanol volume multiple 0.5V-0.8V (33.3%-44.4%) is settled out DS, CS concentrates on the 3rd section, and ethanol volume multiple 0.9V-2.0V (47.4%-66.7%) is settled out CS.

Claims (7)

1. prepare the method for high purity heparin sodium for one kind, it is characterized in that, step is as follows: according to heparin sodium and similar substance thereof, the different solubility in the organic solvent of opposed polarity reaches the separation and purification of heparin sodium and its impurity, thereby prepares highly purified heparin sodium:
Described experimental procedure is as follows:
(1) take 5g heparin industry crude product (containing DS, the CS impurity of different amounts),
(2) add the salt solution that contains certain percentage ratio to be uniformly dissolved,
(3) be V1-V2 (Volume) to adding organic solvent volume multiple in solution,
(4) evenly, normal temperature leaves standstill to be preserved for some time in vibration,
(5) centrifugal, collecting precipitation, then supernatant liquor is regulated to organic solvent volume multiple is V3-V4, evenly, normal temperature leaves standstill to be preserved in vibration,
(6) centrifugal, collecting precipitation, then regulate alcohol volume multiple to be V5-V6 supernatant liquor, centrifugal, collecting precipitation, dries the throw out of every part, weighs.
2. a kind of method of preparing high purity heparin sodium according to claim 1, is characterized in that: the concentration of salt solution used is 2%.
3. a kind of method of preparing high purity heparin sodium according to claim 1, is characterized in that: organic solvent used is ethanol.
4. a kind of method of preparing high purity heparin sodium according to claim 1, is characterized in that: organic solvent volume fraction V1 used is that 9.1%, V2 is 28.6%.
5. a kind of method of preparing high purity heparin sodium according to claim 1, is characterized in that: organic solvent volume fraction V3 used is that 33.3%, V4 is 44.4%.
6. a kind of method of preparing high purity heparin sodium according to claim 1, is characterized in that: the standing time of normal temperature is 2 hours.
7. a kind of method of preparing high purity heparin sodium according to claim 1, is characterized in that: organic solvent volume fraction V5 used is that 47.4%, V6 is 66.7%.
CN201310625500.XA 2013-11-24 2013-11-24 Method of preparing high-purity heparin sodium Pending CN103864958A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310625500.XA CN103864958A (en) 2013-11-24 2013-11-24 Method of preparing high-purity heparin sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310625500.XA CN103864958A (en) 2013-11-24 2013-11-24 Method of preparing high-purity heparin sodium

Publications (1)

Publication Number Publication Date
CN103864958A true CN103864958A (en) 2014-06-18

Family

ID=50904013

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310625500.XA Pending CN103864958A (en) 2013-11-24 2013-11-24 Method of preparing high-purity heparin sodium

Country Status (1)

Country Link
CN (1) CN103864958A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104163878A (en) * 2014-08-13 2014-11-26 南京健友生化制药股份有限公司 Method for producing nadroparin calcium from heparin sodium crude product
CN104448044A (en) * 2014-12-24 2015-03-25 南京健友生化制药股份有限公司 Method for decolorizing heparin sodium and lowering dermatan sulfate content
CN104479048A (en) * 2014-12-24 2015-04-01 青岛九龙生物医药有限公司 Method for removing heparinoid impurities such as DS (dermatan sulfate) and the like in heparin sodium
CN104530257A (en) * 2014-12-24 2015-04-22 青岛九龙生物医药有限公司 Method for separating dermatan sulfate in heparin sodium

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080318328A1 (en) * 2004-03-24 2008-12-25 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
CN101824098A (en) * 2010-02-12 2010-09-08 淮安麦德森化学有限公司 Method for quickly precipitating and separating oversulfated chondroitin sulfate in sodium heparin
CN102633906A (en) * 2011-04-11 2012-08-15 南通天龙畜产品有限公司 Method for removing oversulfated chondroitin sulfate in production process of crude product heparin sodium

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080318328A1 (en) * 2004-03-24 2008-12-25 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
CN101824098A (en) * 2010-02-12 2010-09-08 淮安麦德森化学有限公司 Method for quickly precipitating and separating oversulfated chondroitin sulfate in sodium heparin
CN102633906A (en) * 2011-04-11 2012-08-15 南通天龙畜产品有限公司 Method for removing oversulfated chondroitin sulfate in production process of crude product heparin sodium

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
高晓明: "肝素钠中主要杂质的NMR定量分析方法及污染肝素的分离技术研究", 《中国优秀硕士学位论文全文数据库》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104163878A (en) * 2014-08-13 2014-11-26 南京健友生化制药股份有限公司 Method for producing nadroparin calcium from heparin sodium crude product
CN104448044A (en) * 2014-12-24 2015-03-25 南京健友生化制药股份有限公司 Method for decolorizing heparin sodium and lowering dermatan sulfate content
CN104479048A (en) * 2014-12-24 2015-04-01 青岛九龙生物医药有限公司 Method for removing heparinoid impurities such as DS (dermatan sulfate) and the like in heparin sodium
CN104530257A (en) * 2014-12-24 2015-04-22 青岛九龙生物医药有限公司 Method for separating dermatan sulfate in heparin sodium

Similar Documents

Publication Publication Date Title
CN107011125B (en) Method for enriching cannabidiol
CN110283048B (en) Preparation method of cannabidiol crystal
CN103864958A (en) Method of preparing high-purity heparin sodium
RU2015120458A (en) CLEANING POLYPEPTIDES USING TWO-STAGE ULTRAFILTRATION IN A TANGENTIAL FLOW
CN104069059B (en) A kind of seaweed extracted liquor and its preparation method and application
WO2019143943A3 (en) Composition and method for concentration and enrichment of nucleic acids
CN104356227B (en) High-efficiency concentration and extraction method of serum lipid, lipoprotein and apolipoprotein
JP2017533230A (en) Method for preparing medicinal chlorogenic acid
CN105002160B (en) The DNA of Chinese patent drug or the health products containing Chinese medicine extracting method
CN103601624A (en) Preparation method for ultra pure acetone
CN104558229A (en) Separating and purifying method for Chinese wolfberry polyose
CN102408318A (en) Method for extracting and purifying sequoyitol
CN104557834A (en) Method for separating and purifying pinocembrin, chrysin and galangin from Chinese propolis aqueous extract
CN107556156B (en) Method for extracting palmitoleic acid from natural vegetable oil
CN107266521B (en) Method for extracting cotton mitochondria and protein thereof
CN104479040A (en) Process for extracting bamboo fungus polysaccharide
WO2014194362A8 (en) Process for preparing apolipoprotein a-i (apo a-i)
CN105777938B (en) A method of removing keratan sulfate from chondroitin sulfate crude extract
CN101367728B (en) Method for purifying chicoric acid and monocaffeyltartaric acid from echinacea purpurea extract
CN104557520B (en) A kind of method of separation and purification coffic acid, forulic acid and isoferulic acid from Chinese Water extracts of propolis
Schwerdtner et al. The separation of male and female: A comparison of seven protocols (P)
CN104530257A (en) Method for separating dermatan sulfate in heparin sodium
US9745260B2 (en) Method for purifying acrylamide alkyl sulfonic acid
CN105777530A (en) Method for extracting carnosic acid from rosmarinus officinalis
CN102285954B (en) Method for extracting epicatechin from red bayberry fruit residues

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140618